Originator
#	Product	Brand	Company	Indication	DMF availability
1	Aripiprazole	Abilify	Otsuka	Antipsychotic	2nd quarter 2010
2	Clopidogrel Form I	Plavix	Sanofi	Platetelet Aggregation	Available
3	Donepezil HCl	Aricept	Eisai	Alzheimer's Dementia	1st quarter 2011
4	Duloxetine HCl	Cymbalta	Lilly	Depression	3rd quarter 2010
5	Esomeprazole Magnesium Trihydrate	Nexium	Astra Zeneca	Gastric Ulcer	2nd quarter 2010
6	Ibandronate Sodium	Boniva	Roche	Osteoporosis	2nd quarter 2010
7	Itraconazole	Sporanox	Janssen	Fungal Infections	CEP
8	Lansoprazole	Prevacid	Takeda	Gastric Ulcer	Available
9	Olanzapine Form I	Zyprexa	Lilly	Depression	Available
10	Omeprazole	Losec	Astra Zeneca	Gastric Ulcer	CEP
11	Omeprazole Magnesium	Losec	Astra Zeneca	Gastric Ulcer	1st quarter 2010
12	Omeprazole Sodium	Prilosec	Astra Zeneca	Gastric Ulcer	1st quarter 2010
13	Pantoprazole Na Sesquihydrate	Protonix	Takeda	Gastric Ulcer	4th quarter 2009
14	Pregabalin	Lyrica	Pfizer	Neuropsychiatry	3rd quarter 2010
15	Rabeprazole Na Sesquihydrate	Aciphex	Eisai	Gastric Ulcer	1st quarter 2010
16	Sertraline HCl Form II	Zoloft	Pfizer	Depression	Available
17	Venlafaxine HCl	Effexor	Wyeth	Depression	Available
18	Voriconazole	Vfend	Pfizer	Fungal Infections	Available
Note: APIs with non-infringing support offered wherever required
R&D Development Projects undertaken
EU CTD and US DMFs in advanced stages for generic and near expiry products
Technical Package ready for all / most of the listed products
Impurity Standards offered wherever possible
Working Standards for Actives
EU (Danish) inspected facility with complete documentation and traceability